SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000950170-23-010020
Filing Date
2023-03-27
Accepted
2023-03-27 16:31:44
Documents
91

Document Format Files

Seq Description Document Type Size
1 POS AM cmra-20230327.htm   iXBRL POS AM 5253756
2 EX-23.2 cmra-ex23_2.htm EX-23 4635
3 GRAPHIC img241130555_0.jpg GRAPHIC 117597
4 GRAPHIC img241130555_1.jpg GRAPHIC 116051
5 GRAPHIC img241130555_2.jpg GRAPHIC 41962
  Complete submission text file 0000950170-23-010020.txt   14302471

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20230327.xsd EX-101.SCH 96654
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20230327_pre.xml EX-101.PRE 499457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20230327_def.xml EX-101.DEF 328185
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20230327_lab.xml EX-101.LAB 641283
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmra-20230327_cal.xml EX-101.CAL 65316
85 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20230327_htm.xml XML 1877372
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-264686 | Film No.: 23764911
SIC: 2834 Pharmaceutical Preparations